EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health)

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

EnoSTIM™ is a PROPRIETARY SYNERGISTIC FORMULATION developed by Nexira (France) for male sexual health — combining apple polyphenols, grape polyphenols, and saffron extract. Distinguished by NutraIngredients 'Ingredient of the Year' award (Healthy Aging category), 4-week clinical study showing 74% of men 45+ improved hardness scores, eNOS activation mechanism (up to 50% blood flow increase), and 74% reduction in oxidative stress. Used as natural alternative or adjunct for male sexual function, particularly for older men.

Studied Dose 600 mg/day (research-validated dose)
Active Compound Apple polyphenols + Grape polyphenols + Saffron extract (proprietary synergistic ratio)

Benefits

Male Sexual Performance / Hardness Score Improvement

Nexira 4-week trial in men aged 45+ showed 74% of volunteers improved their hardness score with EnoSTIM™ 600 mg/day. Validated questionnaires assessed outcomes. Established efficacy in target demographic.

Endothelial Nitric Oxide Synthase (eNOS) Activation

In vitro and ex vivo studies showed EnoSTIM™ activates eNOS — the enzyme producing nitric oxide for vasodilation. Increases blood flow up to 50%. Foundation mechanism for sexual performance application.

Oxidative Stress Reduction (74% Decrease)

In vivo study showed EnoSTIM™ scavenges free radicals, protecting NO action and decreasing oxidative stress 74%. Vascular oxidative stress is implicated in age-related erectile dysfunction.

Healthy Blood Flow Properties

Combined eNOS activation + oxidative stress reduction supports vascular function — relevant to: sexual performance, cardiovascular health, age-related vascular concerns.

Saffron Synergy for Sexual Health

Saffron has documented sexual health applications (some EFSA pending claims for erection improvement). Combined with polyphenols, theoretical synergistic effect.

Mechanism of action

1

eNOS Activation → Increased Nitric Oxide → Vasodilation

EnoSTIM™ activates endothelial nitric oxide synthase — increases NO production in vascular endothelium — vasodilation — increased blood flow. Essential mechanism for penile erection (filling of corpora cavernosa requires adequate blood flow). Same fundamental NO pathway as PDE5 inhibitors target downstream.

2

Antioxidant Protection of NO

NO is rapidly inactivated by reactive oxygen species in oxidative stress. EnoSTIM™'s antioxidant activity protects NO from degradation — enhances NO bioavailability and effects. Particularly relevant in older men where oxidative stress contributes to sexual dysfunction.

3

Apple + Grape Polyphenols

Combined polyphenol fraction provides antioxidant activity, vascular endothelial support, anti-inflammatory effects. Complementary mechanisms to saffron's serotonergic and circulatory effects.

4

Saffron Sexual Health Mechanism

Saffron has documented effects on sexual function via multiple pathways — neurotransmitter modulation, vascular effects, antidepressant effects (depression frequently underlies sexual dysfunction). Saffron has EFSA pending claim for erection improvement and muscle relaxation.

Clinical trials

1
EnoSTIM™ in Men 45+ — Nexira 4-Week Study

Trial of EnoSTIM™ 600 mg/day in men aged 45 and over over 4 weeks.

Men aged 45+.

74% of volunteers improved their hardness score by week 4. Validated questionnaires used. Established efficacy in target demographic.

2
EnoSTIM™ eNOS Activation — In Vitro/Ex Vivo

In vitro and ex vivo studies of EnoSTIM™ effects on eNOS activity and blood flow.

In vitro / ex vivo.

Activated eNOS; increased blood flow up to 50%. Established mechanism foundation.

About this ingredient

About the active ingredient

ENOSTIM™ is a PROPRIETARY MALE SEXUAL HEALTH FORMULATION developed by NEXIRA (France) — combining APPLE polyphenols, GRAPE polyphenols, and SAFFRON (Crocus sativus) extract in synergistic ratio. RECOGNITION: NutraIngredients 'Ingredient of the Year' award in HEALTHY AGING category. POSITIONING: 'THE NATURAL MALE ENHANCER' — focus on healthy blood flow properties for age-related sexual function support. CLINICAL EVIDENCE: 4-week trial in men 45+ (74% improvement in hardness scores); in vitro and ex vivo studies on eNOS activation; in vivo oxidative stress reduction.

KEY MECHANISTIC FINDINGS: (1) eNOS activation increases blood flow up to 50%; (2) Free radical scavenging decreases oxidative stress by 74%. INGREDIENTS: (1) APPLE POLYPHENOLS — quercetin, catechins, chlorogenic acid; vascular endothelial support; (2) GRAPE POLYPHENOLS — resveratrol, OPCs, anthocyanins; antioxidant and vascular benefits; (3) SAFFRON (Crocus sativus) — crocins, safranal; sexual health pending EFSA claim ('improves erection and relaxes muscles'); mood support also relevant.

EVIDENCE-BASED USES: (1) MALE SEXUAL PERFORMANCE in men 45+; (2) Erectile function support (modest, complementary to PDE5 inhibitors); (3) Healthy blood flow / vascular support; (4) Age-related sexual function decline; (5) Oxidative stress in vascular tissue.

CRITICAL CAUTIONS: (1) ED MEDICAL EVALUATION — erectile dysfunction is often a marker of cardiovascular disease; men experiencing ED should have cardiovascular evaluation (lipids, BP, glucose, vascular assessment); EnoSTIM is supportive, not replacement for medical evaluation; (2) PDE5 INHIBITOR INTERACTION — additive vasodilation; theoretical hypotension; consult prescriber if combining EnoSTIM with sildenafil/tadalafil/vardenafil; (3) NITRATE INTERACTION — DO NOT COMBINE with nitrate medications (nitroglycerin, isosorbide) due to risk of severe hypotension; (4) ANTIHYPERTENSIVE COMBINATION — additive BP reduction; modest concern; (5) DOSE — 600 mg/day per Nexira recommendation; product specifies dosing format; (6) ONSET OF EFFECT — 4-week trial duration; not single-dose mechanism (unlike PDE5 inhibitors); requires consistent use for maximum effect; (7) FOR PSYCHOGENIC ED — saffron component's mood support may help if anxiety/depression contributing to ED; comprehensive approach (psychological, relationship, medical) often needed; (8) AGE 45+ POPULATION — clinical evidence specifically in this demographic; younger men may benefit but evidence specific to older population; (9) NATURAL VS PHARMACEUTICAL — EnoSTIM's effect smaller than PDE5 inhibitors but provides chronic support without prescription; reasonable for: mild-moderate age-related decline, men avoiding prescription medications, complementary use with prescriptions; (10) SAFFRON COMPONENT — provides additional mood support which may be beneficial since mood issues often accompany sexual dysfunction; (11) ALLERGIES — Asteraceae family allergy possible (saffron); rare; (12) APPLICATIONS — food supplements; tablet, capsule formats; (13) ENOS ACTIVATION — distinct mechanism from substrate-providing approaches (e.g., L-arginine, citrulline); polyphenol-mediated eNOS activation may have different time course; (14) BRAND VERIFICATION — EnoSTIM™ is Nexira trademark; clinical evidence specific to this proprietary formulation; generic apple+grape+saffron combinations may have different effects; (15) INTEGRATIVE MEN'S HEALTH — EnoSTIM is one component of comprehensive approach including: cardiovascular health, weight management, stress reduction, sleep quality, relationship/psychological factors.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress (rare).
Headache rare.
Dizziness from vasodilation (rare).
Allergic reactions to ingredients rare.
Saffron-related cautions (Asteraceae family allergy).

Important Drug interactions

PDE5 INHIBITORS (sildenafil, tadalafil, vardenafil) — additive vasodilation; theoretical hypotension; consult prescriber.
NITRATES (nitroglycerin, isosorbide) — additive NO/vasodilation; theoretical severe hypotension; AVOID combination.
ANTIHYPERTENSIVES — additive BP reduction; modest concern.
Anticoagulants — theoretical antiplatelet effects from polyphenols; minor.
ANTIDEPRESSANTS — saffron component has serotonergic activity; theoretical interaction.
Pregnancy — N/A (male product); consult for partner safety if relevant.

Frequently asked questions about EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health)

What is the recommended dosage of EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health)?

The clinically studied dose for EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health) is 600 mg/day (research-validated dose). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health) used for?

EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health) is studied for male sexual performance / hardness score improvement, endothelial nitric oxide synthase (enos) activation, oxidative stress reduction (74% decrease). Nexira 4-week trial in men aged 45+ showed 74% of volunteers improved their hardness score with EnoSTIM™ 600 mg/day. Validated questionnaires assessed outcomes. Established efficacy in target demographic.

Are there side effects from taking EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health)?

Reported potential side effects may include: Generally well-tolerated. Mild GI distress (rare). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health) interact with medications?

Known drug interactions may include: PDE5 INHIBITORS (sildenafil, tadalafil, vardenafil) — additive vasodilation; theoretical hypotension; consult prescriber. NITRATES (nitroglycerin, isosorbide) — additive NO/vasodilation; theoretical severe hypotension; AVOID combination. Consult a pharmacist or healthcare provider if you take prescription medications.

Is EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health) good for men's health?

Yes, EnoSTIM™ (Apple-Grape-Saffron for Male Sexual Health) is researched for Men's Health support. Nexira 4-week trial in men aged 45+ showed 74% of volunteers improved their hardness score with EnoSTIM™ 600 mg/day. Validated questionnaires assessed outcomes. Established efficacy in target demographic.